Dr. Antzelevitch, a cardiovascular research scientist internationally known for his work in cardiac electrophysiology and arrhythmia syndromes, titled his lecture “Genetic, Ionic and Cellular Mechanisms Underlying the J Wave Syndromes.” Dr. Antzelevitch, as well as LIMR Professor, Dr. Gan-Xin Yan, recently convened an international task force of leading experts to develop a consensus report and a book on the subject of J Wave Syndromes. The report is due to be published by June in three medical journals simultaneously.

To select the Zipes award winner, the HRS president and Scientific Sessions Program Committee Chair poll the basic science community and present a recommendation for the winner of the award to the President of the Cardiac Electrophysiology Society (CES), who makes the final selection.

Dr. Antzelevitch’s recent awards and honors include the Distinguished Scientist Award from the North American Society of Pacing and Electrophysiology (currently HRS); Excellence in Cardiovascular Science Award of the American Heart Association; Carl J. Wiggers Award of the American Physiological Society; the Distinguished Scientist Award of the American College of Cardiology; and the Distinguished Service Award of CES.

Over the years, Dr. Antzelevitch has served on many HRS committees, including the Board of Trustees. His contributions to the scientific literature include more than 500 original papers, reviews and book chapters, and seven books. He currently serves as Associate Editor of HeartRhythm, the official journal of the Heart Rhythm Society and Secretary-Treasurer of Cardiac Electrophysiology Society.

Lankenau Institute for Medical Research (LIMR) is a nonprofit biomedical research institute located on the campus of Lankenau Medical Center and is part of Main Line Health. Founded in 1927, LIMR’s mission is to improve human health and well-being. Faculty and staff are devoted to advancing innovative new approaches to formidable medical challenges, including cancer, cardiovascular disease, gastrointestinal disorders and autoimmune diseases, such as diabetes and arthritis. LIMR’s principal investigators conduct basic, preclinical and translational research, using their findings to explore ways to improve disease detection, diagnosis, treatment and prevention. They are committed to extending the boundaries of human health through technology transfer and training of the next generation of scientists and physicians.